Skip to main content
OpenTrials

Clinical trial condition

Adult T-Cell Leukemia/Lymphoma

Explore clinical trials studying Adult T-Cell Leukemia/Lymphoma. Study availability and eligibility vary by location and protocol.

12 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Adult T-Cell Leukemia/Lymphoma trial results

Recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

NCT04301076

Conditions
Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma, +21 more
Locations
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri, United States
  • Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States
View all 19 locations
View Trial Details
Recruiting

A Registry for People With T-cell Lymphoma

NCT05978141

Conditions
Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
Locations
  • City of Hope Cancer Center (Data collection only) Duarte, California, United States
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
  • University of California San Francisco (Data collection only) San Francisco, California, United States
  • Stanford University Medical Center (Data collection only) Stanford, California, United States
View all 26 locations
View Trial Details
Completed

A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)

NCT02588651

Conditions
Adult T-Cell Leukemia/Lymphoma, Angioimmunoblastic T-cell Lymphoma, Enteropathy Associated T-cell Lymphoma, +22 more
Locations
  • Wayne State University, Karmanos Cancer Institute Detroit, Michigan, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

NCT02631746

Conditions
Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma, +23 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
View Trial Details
Completed

Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma

NCT04102150

Conditions
Adult T-Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Ehime University Hospital Tōon-shi, Ehime, Japan
  • Kyushu University Hospital Fukuoka, Japan
View all 24 locations
View Trial Details

Related conditions